Augustine Therapeutics
Biotechnology Research
Leuven, Vlaams Brabant, Be
24 employees
- Employees
- 24
- Contacts
- 3
- Emails
- 3
- Phones
- 1
Augustine Therapeutics Overview
- Headquarters
- Leuven, Vlaams Brabant, Be
- Website
- augustinetx.com
- Industry
- Biotechnology Research
- Employees
- 24
- Founded
- 2019
- Funding
- 84.1M
- Company Email
- Available in AeroLeads
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
About Augustine Therapeutics
Augustine Therapeutics is a biotechnology company focused on the treatment of neuromuscular, neurodegenerative and cardio-metabolic diseases through its next-generation approach to selectively inhibit HDAC6. Augustine’s HDAC6 inhibitors have been purposefully designed to selectively inhibit HDAC6 while preserving its beneficial non-catalytic functions. Augustine’s lead program, AGT-100216, is the first selective HDAC6 inhibitor for long-term treatment of Charcot-Marie-Tooth (CMT) disease. With its novel non-hydroxamate, non-hydrazide producing chemotype, Augustine’s HDAC6 approach is selective, avoids the limitations of other chemotypes, and built for chronic diseases. With this novel approach, the Company will also be targeting diseases beyond CMT, including neurodegenerative and cardio-metabolic diseases. Augustine Therapeutics was founded on the ground-breaking research of Prof. Ludo Van Den Bosch from the VIB-KU Leuven in Belgium. ——— *Disclaimer* ——— We wish to caution jobseekers that Augustine Therapeutics, only recruits for the positions that are posted on the company’s webpage and via the channels mentioned there. It will also not charge fees of any kind from candidates during the recruitment process. Any person or organization dealing with unauthorized parties is doing so at their own risk.
Augustine Therapeutics Contact Details
- People in AeroLeads
- 4
- With contact data
- 3
- Email contacts
- 3
- 75.0% coverage
- Phone contacts
- 1
- 25.0% coverage
Augustine Therapeutics Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Virginie Cartage | Belgium |
Email
|
|
| Rie Schultz Hansen |
View
|
||
| Pascale Witz | Chair, Board Director, Advisor, Former CEO, Investor, Author / Pharma & Biotech, Digital Health, Medtech | New York City Metropolitan Area, United States |
Email
Phone
|
| Emmanuelle Coutanceau | Partner at Novo Holdings | Copenhagen, Capital Region of Denmark, Denmark |
Email
|
Employees by Management Level
Executive
1 profile
VP / Head
1 profile
Individual contributor
1 profile
Department Contact Coverage
| Department | Contacts | Phone | |
|---|---|---|---|
| General | 1 | 1 | 1 |
Compare Similar Companies to Augustine Therapeutics
Confo Therapeutics
Biotechnology
Agomab
Biotechnology Research
Averna Therapeutics
Biotechnology Research
Character Biosciences
Biotechnology
Hillstar Bio
Biotechnology Research
Rewind Therapeutics
Biotechnology Research
Flamingo Therapeutics
Biotechnology Research
Asabys Partners
Venture Capital And Private Equity Principals
Montis Biosciences
Biotechnology Research
Tempero Bio
Biotechnology Research